Ionizing Radiation-treated NRF2-deficient Cancer Cells Promote Type I Interferon Signaling in Immune Cells. Seo HR, Kim HJ, Ryu H, Song JY, et al. Anticancer Res 2024;44:2577-2585.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Seo HR, Kim HJ, Ryu H, Song JY, et al. Ionizing Radiation-treated NRF2-deficient Cancer Cells Promote Type I Interferon Signaling in Immune Cells. Anticancer Res 2024;44:2577-2585.
PMID: 38821598